Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution

Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy

(2021) Jianzhou Chen et al.   CLINICAL CANCER RESEARCH

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

(2021) Nasser K Altorki et al.   LANCET ONCOLOGY

Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

(2021) Fernanda G Herrera et al.   Cancer Discovery

Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer

(2020) Akinori Sasaki et al.   Gastric Cancer

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

(2020) Karim Fizazi et al.   EUROPEAN UROLOGY

Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation

(2020) B.A. Dyer et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer

(2020) Christine H. Feng et al.   SEMINARS IN RADIATION ONCOLOGY

Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy

(2019) Eric Deutsch et al.   LANCET ONCOLOGY

Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer

(2019) Pippa F. Cosper et al.   INTERNATIONAL JOURNAL OF CANCER